In 2017, the global elderly nutrition market was valued at US$ 17,453.5 million, and it is predicted to grow at a CAGR of 6.6 percent from 2018 to 2026.

          Elderly Nutrition Market

Elderly Nutrition Market support for healthy aging and prevention of malnutrition and vitamin deficiencies are important aspects of advanced healthcare in the geriatric segment. Vitamins, proteins, minerals, lipids, fibers, and other vital substances are found in elderly nutrition products, which help to regulate body functions and boost immunity.

The Elderly Nutrition Market is predicted to develop in response to rising rates of neurological disorders and chronic diseases among the elderly.

Geriatric people who are extremely susceptible to numerous problems such as diabetes, obesity, renal failures, chronic diseases, and others are advised to consume an elderly diet. Furthermore, the increased frequency of age-related ailments in geriatric patients, such as organ failures, neurological disorders, and cardiovascular diseases, is likely to fuel market expansion.

Furthermore, the growing geriatric population, as well as a lack of nutritious intake through food, is expected to propel the elderly nutrition market forward over the forecast period. Global geriatric population was around 962 million in 2017, according to World Population Prospects, and is anticipated to reach around 2.1 billion by 2050.

When it comes to nutrition delivery in the elderly, the routes of administration, such as oral, parenteral, and enteral, are critical.

The rising prevalence of chronic diseases in Europe is likely to drive market expansion.

Due to the high frequency of chronic diseases such as cancer and cardiovascular disorders in the region, Europe enjoys a strong position in the elderly nutrition industry.

According to the European Heart Network's 2017 factsheet, around 11.3 million new instances of cardiovascular diseases were documented in Europe, with approximately 6.1 million cases being registered in the European Union (EU).

Key Players

Major players operating in the global elderly nutrition market include Allergan, Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Danone, Fresenius Kabi AG, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC, and Sanofi.